ARGENX SE is 2.9x more valuable than Moderna, Inc. by market capitalization ($53.35 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRNA | ARGX |
|---|---|---|
| Market cap | $18.25 B | $53.35 B |
| US-listed rank | #650 | #306 |
| Revenue (latest FY) | $1.94B | - |
| Net income (latest FY) | -$2.82B | - |
| Net margin | -145.2% | - |
| SEC filings | 1,447 | 272 |
ARGENX SE is 2.9x more valuable than Moderna, Inc. by market capitalization ($53.35 B vs $18.25 B).
Full pages: Moderna, Inc. and ARGENX SE, or browse the full rankings.